Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Clinical trial NCT06465199 · RECRUITING

Trial details

NCT number: NCT06465199
Sponsor: Milton S. Hershey Medical Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Atypical Teratoid/Rhabdoid Tumor Embryonal Tumor With Multilayered Rosettes Ewing Sarcoma Diffuse Intrinsic Pontine Glioma Osteosarcoma Neuroblastoma DIPG Brain Tumor

Start date: 2026-05-13
Primary completion: 2033-05-01
Enrollment: 289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.